These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1282675)

  • 1. [Hepatitis C; current developments in diagnosis and therapy].
    Willems M; Moshage H; Fevery J; Yap SH
    Ned Tijdschr Geneeskd; 1992 Dec; 136(52):2564-7. PubMed ID: 1282675
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in antibodies to specific hepatitis C virus antigens with interferon-alpha therapy: analysis by recombinant immunoblot assay.
    Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
    Am J Gastroenterol; 1993 Jun; 88(6):914-8. PubMed ID: 7684885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C: the 'silent stalker'.
    Harkness GA
    Am J Nurs; 2003 Sep; 103(9):24-5. PubMed ID: 14506802
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current aspects of hepatitis C].
    Henry JP; Hayard P; Hayani A; Ligny G
    Rev Med Brux; 1994; 15(4):211-5. PubMed ID: 7524123
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis C: diagnosis and treatment.
    Scotiniotis I; Brass CA; Malet PF
    J Gen Intern Med; 1995 May; 10(5):273-82. PubMed ID: 7542329
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis C virus serotype II responds more favorably to interferon-alpha therapy.
    Orito E; Mizokami M; Mizoguchi N; Ohba K; Tohnai M; Yamanaka H; Oguri T; Hirashima N; Koide T; Kano H
    J Hepatol; 1994 Jul; 21(1):130-2. PubMed ID: 7525694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of early interferon alfa therapy for hepatitis C virus infection recurrence after liver transplantation.
    Boillot O; Berger F; Rasolofo E; Mion F; Chevallier P; Gille D; Paliard P
    Transplant Proc; 1995 Aug; 27(4):2501. PubMed ID: 7544508
    [No Abstract]   [Full Text] [Related]  

  • 8. The discovery of the NANB hepatitis virus by gene technology.
    Decker RH
    Beitr Infusionsther; 1992; 30():6-12. PubMed ID: 1284768
    [No Abstract]   [Full Text] [Related]  

  • 9. Early prediction of successful alpha-interferon therapy of chronic hepatitis C by core-IgM antibodies to hepatitis C virus.
    Tassopoulos NC; Hatzakis AE; Papatheodoridis GV; Karvountzis G; Troonen H; Lennartz L
    J Hepatol; 1994 Feb; 20(2):305-6. PubMed ID: 7516362
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical significance of antibody to Y19 protein in nonA and nonB chronic liver disease].
    Sakashita H
    Fukuoka Igaku Zasshi; 1993 Apr; 84(4):159-72. PubMed ID: 7686128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of interleukin-8 in hepatitis C virus infection: relation to combined peg-interferon ribavirin response and genotype 4.
    El Sayed ZM; Mansour FA; Ghal MF; Abou-Zahra SB
    Immunol Invest; 2011; 40(1):29-38. PubMed ID: 20809700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biological diagnosis of hepatitis C virus infection].
    Gérard C; Sondag D
    Rev Med Liege; 1995 Mar; 50(3):110-6. PubMed ID: 7536952
    [No Abstract]   [Full Text] [Related]  

  • 13. [Application of C8-2Ag-Ab system for the diagnosis of hepatitis C].
    Mizuno K; Kawahara T; Fujiyama S; Yano M
    Nihon Rinsho; 1991 Feb; 49(2):330-4. PubMed ID: 1707102
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis C virus antibody in Swaziland.
    Aceti A; Taliani G; Bruni R; Di Mauro G; Celestino D
    Acta Trop; 1992 Jun; 51(2):159-61. PubMed ID: 1380766
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-hepatitis C virus immunoglobulin M antibody in patients with chronic hepatitis type C.
    Kikuchi T; Onji M; Michitaka K; Ohta Y
    Hepatogastroenterology; 1992 Dec; 39(6):525-8. PubMed ID: 1336473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acute hepatitis C with interferon alfa-2b.
    Tocci G; Visco-Comandini U; Antonucci G
    N Engl J Med; 2002 Apr; 346(14):1091-2. PubMed ID: 11936121
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy.
    Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1993 Jun; 17(6):960-5. PubMed ID: 7685734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
    Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
    Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [IFN in the treatment of chronic viral hepatitis. Efficacy and tolerance of lymphoblastoid alpha interferon in HIV-negative drug addicts and associated chronic active hepatitis C].
    Acone N; B1ll'Aquila G; Magliocca M; Nigro FS; Pacifico P; Imparato L
    Clin Ter; 1994 Nov; 145(11):369-72. PubMed ID: 7534222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of antibody to hepatitis C E2/NS1 protein in patients with type C hepatitis.
    Yokosuka O; Ito Y; Imazeki F; Ohto M; Omata M
    Biochem Biophys Res Commun; 1992 Nov; 189(1):565-71. PubMed ID: 1280430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.